Reducing dietary sodium and decreases in cardiovascular disease in Canada

Canadian Journal of Cardiology

Volumn 24, Issue 6, 2008, Pages 497-501

  Penz, Erika D ^a   Joffres, Michel R ^b   Campbell, Norm R C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Blood pressure; Cardiovascular disease; Dietary sodium

Indexed keywords

DIURETIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; BLOOD PRESSURE REGULATION; CANADA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH PROMOTION; HEART FAILURE; HUMAN; HYPERTENSION; META ANALYSIS; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; SODIUM INTAKE; SODIUM RESTRICTION; STROKE; SYSTEMATIC REVIEW; DIET THERAPY; METHODOLOGY; MORBIDITY; REVIEW;

CANADA; CARDIOVASCULAR DISEASES; DIET, SODIUM-RESTRICTED; HUMANS; META-ANALYSIS AS TOPIC; MORBIDITY; SODIUM, DIETARY;

EID: 46249092606     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70625-1     Document Type: Article

References (30)

1. Johansen H, Thillaiampalam S, Nguyen D, Sambell C. Diseases of the circulatory system - hospitalization and mortality. Health Rep 2005;17:49-53.
2. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-60.
3. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis. JAMA 2003;289:2534-44.
4. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension:. Analysis of worldwide data. Lancet 2005;365:217-23.
5. MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet 1989;2:1244-7.
6. Sacks FM, Svetkey LP, Vollmer WM, et al; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. New Engl J Med 2001;344:3-10.
7. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003;42:1093-9.
8. World Health Organization. Reducing salt intake in populations: Report of a WHO forum and technical meeting. Geneva: World Health Organization Press, 2007:1-65.
9. Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Sodium and Chloride. Washington: National Academy Press, 2004:269-423.
10. Joffres MR, Campbell NR, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol 2007;23:437-43.
11. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database System Rev 2004;(1):CD004937.
12. Kannel WB, Wolf PA, Verter J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA 1970;214:301-10.
13. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
14. Haider AW, Chen L, Larson MG, Evans JC, Chen MH, Levy D. Antecedent hypertension confers increased risk for adverse outcomes after initial myocardial infarction. Hypertension 1997;30:1020-4.
15. Heart and Stroke Foundation of Canada. The changing face of cardiovascular disease in Canada. Ottawa: Heart and Stroke Foundation of Canada, 1999:45-64.
16. Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr 1991;10:383-93.
17. Garriguet D. Sodium consumption at all ages. Health Rep 2007;18:47-52.
18. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 1995;25:1144-52.
19. Logan AG. Dietary sodium intake and its relation to human health: A summary of the evidence. J Am Coll Nutr 2006;25(Suppl 3):5 p preceding 231S.
20. Scientific Advisory Committee on Nutrition. Salt and Health. London: The Stationery Office, 2003:1-134.
21. Cook NR, Cutler JA, Obarzanek F, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007;334:885-92.
22. Chang HY, Hu YW, Yue CS, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr 2006;83:1289-96.
23. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006;49:59-75.
24. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: Health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007;370:2044-53. (Erratum in 2007;370:2004).
25. Jackson EK. Diuretics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edn. New York: McGraw-Hill Companies, 2006. Chapter 28 (online).
26. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. (Erratum in 2003;361:1060).
27. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997;126:761-7.
28. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41. (Errata in 2001;358:1556, 2002;359:2120).
29. Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet 2007;370:829-40.
30. Pimenta E, Calhoun DA. Aldosterone, dietary salt, and renal disease. Hypertension 2006;48:209-10.